FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100895228> ?p ?o ?g. }

• W3100895228 endingPage "917" @default.
• W3100895228 startingPage "917" @default.
• W3100895228 abstract "The identification of affordable noninvasive biomarkers for the diagnosis and characterization of nonalcoholic fatty liver disease (NAFLD) is a major challenge for the research community. This study aimed to explore the usefulness of ferritin as a proxy biomarker of NAFLD condition, alone or in combination with other routine biochemical parameters. Subjects with overweight/obesity and ultrasound-confirmed liver steatosis (n = 112) from the Fatty Liver in Obesity (FLiO) study were assessed. The hepatic evaluation considered magnetic resonance imaging, ultrasonography, and credited routine blood liver biomarkers. Anthropometry and body composition, dietary intake (by means of a validated 137-item food frequency questionnaire), and specific biochemical markers were also determined. Serum ferritin levels were analyzed using a chemiluminescent microparticle immunoassay kit. Lower serum ferritin concentrations were associated with general better liver health and nutritional status. The evaluation of ferritin as a surrogate of liver damage by means of quantile regression analyses showed a positive association with alanine aminotransferase (ALT) (β = 19.21; p ≤ 0.001), liver fat content (β = 8.70; p = 0.008), and hepatic iron (β = 3.76; p ≤ 0.001), after adjusting for potential confounders. In receiver operating characteristic (ROC) analyses, the panel combination of blood ferritin, glucose, and ALT showed the best prediction for liver fat mass (area under the curve (AUC) 0.82). A combination of ferritin and ALT showed the higher predictive ability for estimating liver iron content (AUC 0.73). This investigation demonstrated the association of serum ferritin with liver health as well as with glucose and lipid metabolism markers in subjects with NAFLD. Current findings led to the identification of ferritin as a potential noninvasive predictive biomarker of NAFLD, whose surrogate value increased when combined with other routine biochemical measurements (glucose/ALT)." @default.
• W3100895228 created "2020-11-23" @default.
• W3100895228 creator A5001444500 @default.
• W3100895228 creator A5003280346 @default.
• W3100895228 creator A5011852397 @default.
• W3100895228 creator A5018511259 @default.
• W3100895228 creator A5020950822 @default.
• W3100895228 creator A5027827192 @default.
• W3100895228 creator A5035385579 @default.
• W3100895228 creator A5035520668 @default.
• W3100895228 creator A5038066495 @default.
• W3100895228 creator A5045195222 @default.
• W3100895228 creator A5053901119 @default.
• W3100895228 creator A5067889396 @default.
• W3100895228 date "2020-11-08" @default.
• W3100895228 modified "2023-10-01" @default.
• W3100895228 title "Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study" @default.
• W3100895228 cites W1538118659 @default.
• W3100895228 cites W1942877788 @default.
• W3100895228 cites W1976913734 @default.
• W3100895228 cites W1982434499 @default.
• W3100895228 cites W1982791756 @default.
• W3100895228 cites W1997977268 @default.
• W3100895228 cites W2008958864 @default.
• W3100895228 cites W2017602185 @default.
• W3100895228 cites W2035576567 @default.
• W3100895228 cites W2053815894 @default.
• W3100895228 cites W2115709314 @default.
• W3100895228 cites W2116404316 @default.
• W3100895228 cites W2120056458 @default.
• W3100895228 cites W2134739883 @default.
• W3100895228 cites W2140405768 @default.
• W3100895228 cites W2147372056 @default.
• W3100895228 cites W2162382402 @default.
• W3100895228 cites W2164389437 @default.
• W3100895228 cites W2180544129 @default.
• W3100895228 cites W2204688218 @default.
• W3100895228 cites W2272500893 @default.
• W3100895228 cites W2338127892 @default.
• W3100895228 cites W2343605311 @default.
• W3100895228 cites W2612793481 @default.
• W3100895228 cites W2726854871 @default.
• W3100895228 cites W2734724639 @default.
• W3100895228 cites W2743597266 @default.
• W3100895228 cites W2765394563 @default.
• W3100895228 cites W278816506 @default.
• W3100895228 cites W2790716135 @default.
• W3100895228 cites W2794354514 @default.
• W3100895228 cites W2802269018 @default.
• W3100895228 cites W2803327096 @default.
• W3100895228 cites W2805142669 @default.
• W3100895228 cites W2890359865 @default.
• W3100895228 cites W2891362974 @default.
• W3100895228 cites W2899390406 @default.
• W3100895228 cites W2901192187 @default.
• W3100895228 cites W2902200420 @default.
• W3100895228 cites W2904971151 @default.
• W3100895228 cites W2905762125 @default.
• W3100895228 cites W2906122346 @default.
• W3100895228 cites W2913086048 @default.
• W3100895228 cites W2913255928 @default.
• W3100895228 cites W2915000266 @default.
• W3100895228 cites W2922340623 @default.
• W3100895228 cites W2939474006 @default.
• W3100895228 cites W2962246162 @default.
• W3100895228 cites W2978444125 @default.
• W3100895228 cites W2981127390 @default.
• W3100895228 cites W3021025582 @default.
• W3100895228 cites W4256302713 @default.
• W3100895228 doi "https://doi.org/10.3390/diagnostics10110917" @default.
• W3100895228 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7695258" @default.
• W3100895228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33171699" @default.
• W3100895228 hasPublicationYear "2020" @default.
• W3100895228 type Work @default.
• W3100895228 sameAs 3100895228 @default.
• W3100895228 citedByCount "5" @default.
• W3100895228 countsByYear W31008952282021 @default.
• W3100895228 countsByYear W31008952282022 @default.
• W3100895228 countsByYear W31008952282023 @default.
• W3100895228 crossrefType "journal-article" @default.
• W3100895228 hasAuthorship W3100895228A5001444500 @default.
• W3100895228 hasAuthorship W3100895228A5003280346 @default.
• W3100895228 hasAuthorship W3100895228A5011852397 @default.
• W3100895228 hasAuthorship W3100895228A5018511259 @default.
• W3100895228 hasAuthorship W3100895228A5020950822 @default.
• W3100895228 hasAuthorship W3100895228A5027827192 @default.
• W3100895228 hasAuthorship W3100895228A5035385579 @default.
• W3100895228 hasAuthorship W3100895228A5035520668 @default.
• W3100895228 hasAuthorship W3100895228A5038066495 @default.
• W3100895228 hasAuthorship W3100895228A5045195222 @default.
• W3100895228 hasAuthorship W3100895228A5053901119 @default.
• W3100895228 hasAuthorship W3100895228A5067889396 @default.
• W3100895228 hasBestOaLocation W31008952281 @default.
• W3100895228 hasConcept C126322002 @default.
• W3100895228 hasConcept C134018914 @default.
• W3100895228 hasConcept C2775934546 @default.
• W3100895228 hasConcept C2776175330 @default.
• W3100895228 hasConcept C2776954865 @default.

• next